Form 4: BLFS Executive Sells Shares for Tax Obligations

BIOLIFE SOLUTIONS EVP & Chief Scientific Officer Aby J. Mathew disposed of 2,255 common shares to cover tax withholding obligations.

Summary

• Aby J. Mathew, Executive Vice President & Chief Scientific Officer of BIOLIFE SOLUTIONS INC (BLFS), reported a transaction on March 19, 2026.
• The transaction involved the disposition of 2,255 shares of common stock.
• These shares were withheld by the Issuer to satisfy tax withholding obligations that arose upon the release of restricted stock units.
• The price per share for the disposition was $19.12.
• Following this transaction, Aby J. Mathew beneficially owns 390,682 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, representing a standard tax-related disposition of shares upon the vesting of restricted stock units, which is a common practice for executives.

Negatives

• A disposition of 2,255 shares of common stock by a key executive occurred.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

StockSavvy.ai notes that Form 4 filings detailing the disposition of shares for tax withholding purposes are a routine and common occurrence for executives receiving equity compensation, such as restricted stock units, across various industries. This type of transaction is a standard part of managing executive compensation and typically does not reflect a change in management's outlook on the company's prospects.

Stakeholder Impact

• Shareholders: The disposition represents a minor reduction in insider ownership, but it is a routine event for tax purposes and is unlikely to have a significant impact on shareholder sentiment or the company's valuation.

Key Dates

Recommendation

This Form 4 reports a routine disposition of shares by an executive to cover tax obligations upon the vesting of restricted stock units. It does not provide new information that would alter the fundamental investment thesis for BIOLIFE SOLUTIONS, hence a 'hold' recommendation is maintained.

Keywords

BIOLIFE SOLUTIONS, BLFS, Form 4, Insider Transaction, Stock Sale, Tax Withholding, Restricted Stock Units, Aby J. Mathew